Possibilities of radionuclide visualization of HER2/neu-positive breast cancer using a radiopharmaceutical based on recombinant targeting molecules DARPin9_29

Epidermal growth receptor HER2/neu is still of great interest, the overexpression of which is most often observed in patients with breast cancer and accounts for 15–20 % of cases. Present methods of HER2/neu determination have a number of significant drawbacks. In recent years, alternative framework...

Full description

Bibliographic Details
Main Authors: O. D. Bragina, V. I. Chernov, A. A. Medvedeva, R. V. Zelchan, M. S. Larkina, S. M. Deyev, V. M. Tolmachev
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Siberian Branch Publishing House 2020-08-01
Series:Сибирский научный медицинский журнал
Subjects:
Online Access:https://sibmed.elpub.ru/jour/article/view/450